AJP - Regu Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 281: R476-R483, 2001;
0363-6119/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mills, T. M.
Right arrow Articles by Wingard, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mills, T. M.
Right arrow Articles by Wingard, C. J.
Vol. 281, Issue 2, R476-R483, August 2001

Endothelin-1-induced vasoconstriction is inhibited during erection in rats

T. M. Mills1,2, D. M. Pollock1,3, R. W. Lewis2, H. S. Branam1, and C. J. Wingard1,3

Departments of 1 Physiology and of 2 Surgery (Urology Section), 3 Vascular Biology Center, Medical College of Georgia, Augusta, Georgia 30912-3000

Recent evidence indicates that endothelin-1 (ET-1) might be a principal vasoconstrictor in the penis. We report that ET-1 injection into the cavernous sinuses before erection sharply reduced the magnitude of subsequent erections. Corpus cavernosum pressure-to-mean arterial pressure ratios (CCP/MAP), with maximal ganglionic stimulation, were 0.62 ± 0.05 before ET-1 injection and 0.31 ± 0.05 after, indicating that ET-1 acted as a vasoconstrictor. When ET-1 was injected during a maximal neurally induced erection, the ability of ET-1 to attenuate subsequent erections was diminished (CCP/MAP 0.75 ± 0.02 before ET-1, 0.61 ± 0.03 after). At submaximal stimulation voltages, injection of ET-1 during erection also attenuated its vasoconstrictive effect. Similarly, when ET-1 was injected during erection induced by intracavernosal injection of the nitric oxide (NO) donor NOR-1, subsequent erections were not significantly suppressed (CCP/MAP 0.53 ± 0.04 before ET-1, 0.45 ± 0.04 after). These findings that ET-1-induced vasoconstriction is attenuated during erection are consistent with the hypothesis that NO mediates erection both by initiating pathways that cause smooth muscle relaxation and by inhibiting the vasoconstrictive actions of ET-1.

smooth muscle relaxation; nonadrenergic noncholinergic stimulation; nitric oxide donors


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Imamura, Y. Waseda, G. V. Marinova, T. Ishibashi, S. Obayashi, A. Sasaki, A. Nagai, and H. Azuma
Alterations of NOS, arginase, and DDAH protein expression in rabbit cavernous tissue after administration of cigarette smoke extract
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R2081 - R2089.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
S. Jesmin, S. Zaedi, N. Yamaguchi, S. Maeda, I. Yamaguchi, K. Goto, and T. Miyauchi
Effects of dual endothelin receptor antagonist on antiapoptotic marker bcl-2 expression in streptozotocin-induced diabetic rats.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1034 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
T. J. Bivalacqua, M. F. Usta, H. C. Champion, P. J. Kadowitz, and W. J. G. Hellstrom
Endothelial Dysfunction in Erectile Dysfunction: Role of the Endothelium in Erectile Physiology and Disease
J Androl, November 1, 2003; 24(6_suppl): S17 - S37.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. J. Wingard, S. Husain, J. Williams, and S. James
RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1145 - R1152.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. P. Granger
Endothelin
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R298 - R301.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. J. Wingard, J. A. Johnson, A. Holmes, and A. Prikosh
Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1572 - R1579.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
S. Granchi, G.B. Vannelli, L. Vignozzi, C. Crescioli, P. Ferruzzi, R. Mancina, M.C. Vinci, G. Forti, S. Filippi, M. Luconi, et al.
Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells
Mol. Hum. Reprod., December 1, 2002; 8(12): 1053 - 1064.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
M. Rajasekaran, A. Kasyan, A. Jain, S.-W. Kim, and M. Monga
Altered Growth Factor Expression in the Aging Penis: The Brown-Norway Rat Model
J Androl, May 1, 2002; 23(3): 393 - 399.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. M. Mills, K. Chitaley, C. J. Wingard, R. W. Lewis, and R. C. Webb
Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation
J Appl Physiol, September 1, 2001; 91(3): 1269 - 1273.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online